Exact Mass: 490.0934

Exact Mass Matches: 490.0934

Found 40 metabolites which its exact mass value is equals to given mass value 490.0934, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lignosulfonic acid

3-(2-Hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulphopropyl)phenoxy]propane-1-sulphonic acid

C20H26O10S2 (490.0967)

D001697 - Biomedical and Dental Materials

O4(?)-[4-((5S)-5-carboxy-beta-D-xylopyranosyloxy)-benzoyl]-D-glucuronic acid|O4(?)-[4-((5S)-5-Carboxy-beta-D-xylopyranosyloxy)-benzoyl]-D-glucuronsaeure

C19H22O15 (490.0959)

Cys Cys Cys Tyr

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H26N4O6S3 (490.1014)

Cys Cys Tyr Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C18H26N4O6S3 (490.1014)

Cys Tyr Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H26N4O6S3 (490.1014)

Tyr Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H26N4O6S3 (490.1014)

2,7-Dibromo-9,9-dihexylfluorene

C25H32Br2 (490.0871)

NSC 42196

C14H26CaO16 (490.0847)

NSC 42196 is an endogenous metabolite.

BENZENESULFONAMIDE,-[2,4-DIFLUORO-3-[[5-(3-PYRIDINYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]PHENYL]-

C25H16F2N4O3S (490.0911)

Poziotinib

C23H21Cl2FN4O3 (490.0975)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

Iridium(III) acetylacetonate

C15H21IrO6 (490.0967)

Calcium Gluceptate

C14H26CaO16 (490.0847)

A - Alimentary tract and metabolism > A12 - Mineral supplements > A12A - Calcium > A12AA - Calcium C78275 - Agent Affecting Blood or Body Fluid > C29730 - Electrolyte Replacement Agent

Hypholomine B

C26H18O10 (490.09)

3,14-Bihispidinyl

C26H18O10 (490.09)

3-(4-Chlorophenyl)sulfonyl-2-imino-1-(2-phenylethyl)-5-dipyrido[1,2-d:3,4-f]pyrimidinone

C25H19ClN4O3S (490.0866)

5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide

C22H20ClFN4O4S (490.0878)

L-threonylcarbamoyladenylate(2-)

C15H19N6O11P-2 (490.0849)

6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[[(4-methylphenyl)thio]methyl]-3-indolecarboxylic acid ethyl ester

C23H27BrN2O3S (490.0926)

N-(3-chlorophenyl)-5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylsulfonyl)-3-methyl-2-benzofurancarboxamide

C23H23ClN2O6S (490.0965)

N-(2-chlorophenyl)-5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylsulfonyl)-3-methyl-2-benzofurancarboxamide

C23H23ClN2O6S (490.0965)

5-(Diethylsulfamoyl)-2-hydroxybenzoic acid [2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl] ester

C20H21F3N2O7S (490.1022)

4-chloro-N-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-N-(2-oxolanylmethyl)benzenesulfonamide

C23H23ClN2O6S (490.0965)

6-[2-(3,4-dihydroxyphenyl)-6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-oxo-2h,3h-furo[3,2-c]pyran-3-yl]-4-hydroxypyran-2-one

C26H18O10 (490.09)

3-{4,5-dihydroxy-2-[(1e)-2-(4-hydroxy-6-oxopyran-2-yl)ethenyl]phenyl}-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

C26H18O10 (490.09)

3-{4,5-dihydroxy-2-[2-(4-hydroxy-6-oxopyran-2-yl)ethenyl]phenyl}-6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

C26H18O10 (490.09)

7'-(acetyloxy)-8,8'-dihydroxy-6,6'-dimethyl-1,1',4,4'-tetraoxo-[2,2'-binaphthalen]-7-yl acetate

C26H18O10 (490.09)

(1s,14r)-4,9,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8,10,12(26),16(25),17,19-heptaene-3,7,15,21-tetrone

C26H18O10 (490.09)

(1r,15r)-3,9,15,21-tetrahydroxy-11,19-dimethyl-6,14,24-trioxaheptacyclo[16.7.1.1⁴,⁸.0¹,¹⁵.0²,¹³.0²²,²⁶.0¹²,²⁷]heptacosa-2(13),3,8(27),9,11,18(26),19,21-octaene-7,17,23-trione

C26H18O10 (490.09)

3,9,15,21-tetrahydroxy-11,19-dimethyl-6,14,24-trioxaheptacyclo[16.7.1.1⁴,⁸.0¹,¹⁵.0²,¹³.0²²,²⁶.0¹²,²⁷]heptacosa-2(13),3,8(27),9,11,18(26),19,21-octaene-7,17,23-trione

C26H18O10 (490.09)

6-[(2r,3r)-2-(3,4-dihydroxyphenyl)-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-oxo-2h,3h-furo[3,2-c]pyran-3-yl]-4-hydroxypyran-2-one

C26H18O10 (490.09)

(1s,4r,14r,24s)-4,9,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8,10,12(26),16(25),17,19-heptaene-3,7,15,21-tetrone

(1s,4r,14r,24s)-4,9,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8,10,12(26),16(25),17,19-heptaene-3,7,15,21-tetrone

C26H18O10 (490.09)

(1s,14r,24s)-3,9,19,24-tetrahydroxy-5-methoxy-17-methyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2,4(26),8,10,12,16(25),17,19-octaene-7,15,21-trione

C26H18O10 (490.09)

4,9,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8,10,12(26),16(25),17,19-heptaene-3,7,15,21-tetrone

C26H18O10 (490.09)